Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.64 -0.01 (-0.65%)
As of: Oct 1, 2026 · 12:59 PM EDT

Transcode Therapeutics (RNAZ) Preferred Dividend Payments (2026)

Updated

Transcode Therapeutics (RNAZ) recorded Preferred Dividend Payments of $115,015 in Q2 2026, down 93.3% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Preferred Dividend Payments (2026) Analysis & Trends

For FY2025, Transcode Therapeutics reported Preferred Dividend Payments of $1.61 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Transcode Therapeutics 1.70 Mn 1.70 Mn - 115,015.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 115,015.00
Mar 31, 2026 1.73 Mn
API Access

Transcode Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=RNAZ&period=max&api_key=YOUR_API_KEY